Publications and Presentations Database
2016
Le, L. Q., Bartnik, N. J., Christensen, K. D., Uhlmann, W. R., Karlawish, J., Obisesan, T., et al.
(2016).
Educating Patients and Care Partners about Mild Cognitive Impairment, APOE, and Alzheimer’s Disease: Findings from the REVEAL Study.
2010
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2010).
How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Royal, C. D. M., Obisesan, T., et al.
(2010).
Perceived personal utility of Alzheimer’s disease genetic susceptibility testing and its influence on post-test responses: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2010).
The psychological impact of learning APOE ε4 increases the risk for cardiovascular disease during genetic risk assessment for Alzheimer’s disease: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Cupples, L. A., et al.
(2010).
Telephone and in-person disclosure of genetic test results: 6-week recall, comprehension, and distress among participants in the REVEAL Study.
2009
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2009).
The Impact of Pleiotropic Information about Cardiovascular Disease Risk on Health Behavior Changes among People Seeking Genetic Susceptibility Testing for Alzheimer’s Disease: Initial Results from a Randomized Trial.
] 